Additional Research Studies Being Conducted by the ITN
Type 1 Diabetes Clinical Trials
T1DES is a clinical study for people with type 1 diabetes who were previously enrolled in an ITN clinical study.
Autoimmune Disease Clinical Trials
BEAT-MS is a clinical trial comparing chemotherapy followed by autologous hematopoietic stem cell transplant (AHSCT) – a type of bone marrow transplantation – to the most effective medicines regularly used to treat relapsing multiple sclerosis.
BRAVOS is a clinical trial evaluating Brentuximab Vendotin treatment for Diffuse Cutaneous Systemic Sclerosis.
Allergy Clinical Trials
ACTIVATE is a clinical trial investigating the impact of the infant microbiome on allergy development.
LEAP Trio is a follow-up to the LEAP study of early peanut consumption. LEAP Trio will investigate the durability of tolerance to peanut allergen in LEAP participants at age 12, development of peanut allergy in younger siblings of LEAP participants, and parental characteristics that may impact development of food allergy.
Transplantation Clinical Trials
REBOOT will test whether a combination of, belimumab and rituximab, is safe and if this combination is more effective at blocking the immune attack on the kidney of patients with Primary Membranous Neuropathy.
TEACH is a clinical trial investigating whether cells from the kidney donor’s bone marrow, called mesenchymal stromal cells (MSCs) will allow kidney transplant recipients to stop immunosuppressive medications.
LITTMUS is a clinical research study testing a new approach to achieve transplant tolerance using the liver transplant recipient’s own T regulatory cells (Tregs).
ALLTOL is an observational clinical study to learn more about tolerance in organ transplantatio
For more information about the ITN and other clinical trials, please visit immunetolerance.org.